At the crossroads between early or delayed antiretroviral therapy initiation during tuberculosis/human immunodeficiency virus coinfection

At the crossroads between early or delayed antiretroviral therapy initiation during tuberculosis/human immunodeficiency virus coinfection

Bibliographic Details
Main Author:	José Alfredo de Sousa Moreira
Format:	Article
Language:	English
Published:	Elsevier 2014-09-01
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867014001378

Similar Items

Reply to “At the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection”
by: Valeria Saraceni, et al.
Published: (2014-09-01)

Adherence to antiretrovirals in people coinfected with the human immunodeficiency virus and tuberculosis
by: Larissa de Araújo Lemos, et al.
Published: (2016-01-01)

Miliary Tuberculosis Coinfection with the Human Immunodeficiency Virus
by: Pallàs, Oriol, et al.
Published: (2010-12-01)

Immune restoration in human immunodeficiency virus and hepatitis C virus coinfected patients after highly active antiretroviral therapy
by: Vicente Sperb Antonello, et al.
Published: (2013-09-01)

Immune restoration in human immunodeficiency virus and hepatitis C virus coinfected patients after highly active antiretroviral therapy
by: Vicente Sperb Antonello, et al.

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients
by: Wim Adriaensen, et al.
Published: (2018-01-01)

Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment
by: Sinha Sanjeev, et al.
Published: (2012-07-01)

Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection
by: Adeboye Azeez, et al.
Published: (2019-01-01)

Aetiology, Clinical Presentation, and Outcome of Meningitis in Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis
by: Smita Bhagwan, et al.
Published: (2011-01-01)

Investigation of urine lipoarabinomannan in human immunodeficiency virus patients with or without coinfection with Tuberculosis in Iran
by: Payam Tabarsi, et al.
Published: (2016-01-01)

Tuberculosis and human immunodeficiency virus coinfection: Epidemiological situation in the department of Meta, 2010- 2015
by: Laura Plata-Casas, et al.
Published: (2018-08-01)

Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment
by: Williams Ngouleun, et al.
Published: (2016-01-01)

Human immunodeficiency virus and the liver: The impact of coinfection with hepatotropic viruses
by: Leonor Huerta, et al.
Published: (2019-03-01)

Genetic diversity of human immunodeficiency viruses and antiretroviral therapy
by: M R Bobkova
Published: (2016-11-01)

Human Immunodeficiency Virus and Tuberculosis Coinfection in a Tertiary Hospital in Southern Brazil: Clinical Profile and Outcomes
by: Francine Teixeira, et al.
Published: (2018-11-01)

Efficacy of Prompt Initiation of Antiretroviral Therapy in the Treatment of Hemophagocytic Lymphohistiocytosis Triggered by Uncontrolled Human Immunodeficiency Virus
by: Bryan P. Fitzgerald, et al.
Published: (2017-01-01)

A prospective study on impact of early initiation of antiretroviral therapy in human immunodeficiency virus-positive adults on immunological status and adverse events
by: Vikas Kumar, et al.
Published: (2019-01-01)

A Non-Integer Variable Order Mathematical Model of Human Immunodeficiency Virus and Malaria Coinfection with Time Delay
by: A. A. M. Arafa, et al.
Published: (2019-01-01)

Miliary tuberculosis in human immunodeficiency virus infected patients not on antiretroviral therapy: Clinical profile and response to shortcourse chemotherapy
by: Swaminathan S, et al.
Published: (2007-01-01)

Coinfection between human immunodeficiency virus and tuberculosis: A consideration on ritonavir-related heme Oxygenase-1 pathway
by: Won Sriwijitalai, et al.
Published: (2019-01-01)

Determinants of discordant immune response in a cohort of human immunodeficiency virus-infected patients initiating antiretroviral therapy
by: Abdullahi Umar, et al.
Published: (2020-01-01)

Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010.
by: Hao Zhu, et al.
Published: (2012-01-01)

Implications for a policy of initiating antiretroviral therapy in people diagnosed with human immunodeficiency virus: the CAPRA research programme
by: Ada Miltz, et al.
Published: (2017-10-01)

Advances in Studies on Prevalence and Interaction Mechanism of Acquired Immunodeficiency Syndrome and Tuberculosis Coinfection
by: Meng Chao, et al.
Published: (2016-12-01)

Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients
by: Dishank Patel, et al.
Published: (2013-01-01)

Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities
by: Julio C. Abarca, et al.
Published: (2020-03-01)

Treatment outcomes in patients infected with multidrug resistant tuberculosis and in patients with multidrug resistant tuberculosis coinfected with human immunodeficiency virus at Brewelskloof Hospital
by: Adewumi, Olayinka Anthony
Published: (2014)

Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients
by: C Brites, et al.

Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients
by: C. Brites, et al.
Published: (2011-01-01)

Effectiveness of early initiation of antiretroviral therapy in adults with HIV associated tuberculosis in Lesotho in 2012
by: Maletsatsi Lenela, et al.
Published: (2017-10-01)

Human Immunodeficiency Virus and Leprosy Coinfection: Challenges in Resource-Limited Setups
by: Charles M. Kwobah, et al.
Published: (2012-01-01)

The Great Impostor: Transaminitis Masking the Coinfection of Syphilis and Human Immunodeficiency Virus
by: Sunit Tolia, et al.
Published: (2017-01-01)

Equal contributions of feline immunodeficiency virus and coinfections to morbidity in African lions
by: Heather Broughton, et al.
Published: (2021-12-01)

Antiretroviral activity of Pterois volitans (red lionfish) venom in the early development of human immunodeficiency virus/acquired immunodeficiency syndrome antiretroviral alternative source
by: Andy Noorsaman Sommeng, et al.
Published: (2019-02-01)

Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan
by: Yi-Chieh Lee, et al.
Published: (2018-02-01)

Genes at the Crossroad of Primary Immunodeficiencies and Cancer
by: Charlotte Derpoorter, et al.
Published: (2018-11-01)

Factors Related to Delayed Antiretroviral Therapy Initiation in HIV Patients
by: Dwi Rahayu NLP, et al.
Published: (2016-09-01)

Effects of undernutrition on survival of human immunodeficiency virus positive children on antiretroviral therapy
by: Animut Alebel, et al.
Published: (2018-02-01)

Hematological profile of newborns exposed to maternal human immunodeficiency virus and antiretroviral therapy
by: Ibrahim Abdulqadir, et al.
Published: (2018-01-01)

Pulmonary toxoplasmosis in human immunodeficiency virus-infected patients in the era of antiretroviral therapy
by: Jorge N Velásquez, et al.
Published: (2016-01-01)